Dr. Agarwal’s Health Care Limited has scheduled a board meeting on February 3, 2026, to review and approve the unaudited financial results for the quarter and nine months ending December 31, 2025 (Q3 2026). Following the announcement, the company will host an earnings/analyst conference call on February 4, 2026. Further details regarding the call will be available on the company website.
Board Meeting Scheduled
A meeting of the Board of Directors of Dr. Agarwal’s Health Care Limited is scheduled for Tuesday, February 03, 2026. The primary agenda is to consider and approve the Unaudited Financial Results (Standalone & Consolidated) for Q3 2026, specifically the quarter and nine months ended December 31, 2025.
Analyst Conference Call
Dr. Agarwal’s Health Care Limited will host an Earnings/Analyst Conference Call on Wednesday, February 04, 2026, to discuss the Financial Results. Details regarding dial-in information for the call are provided.
Conference Call Details
Dr. Adil Agarwal, Whole-time Director and Chief Executive Officer, Mr. Yashwanth Venkat, Chief Financial Officer, and Ms. Aashna Dharia, Head of Investor Relations, will represent Dr. Agarwal’s Health Care Limited on the call.
Important Dates
- February 3, 2026: Board Meeting to approve Q3 2026 Financial Results.
- February 4, 2026: Earnings/Analyst Conference Call at 11:30 A.M. IST.
Dial-in Information
India: +91 22 6280 1308 / +91 22 7115 8161
International Toll-Free Numbers
- Argentina: 0080014243444
- Australia: 0080014243444
- Belgium: 0080014243444
- Canada: 01180014243444
- China: 4008428405
- France: 0800914745
- Germany: 0080014243444
- Hong Kong: 800964448
- Italy: 0080014243444
- Japan: 00531161110
- Netherlands: 08000229808
- Poland: 008001124248
- Singapore: 8001012045
- South Korea: 00180014243444
- Sweden: 0080014243444
- Thailand: 00180014243444
- UK: 08081011573
- USA: 18667462133
Source: BSE
